Quick Answer
Atea Pharmaceuticals, Inc. reported Stockholders Equity of $275.43 million for fiscal year 2025.
Atea Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $275.43M | -37.2% |
| 2024 | $438.87M | -21.0% |
| 2023 | $555.19M | -13.3% |
| 2022 | $640.57M | -9.8% |
| 2021 | $710.08M | +29.6% |
| 2020 | $547.80M | +1205.1% |
| 2019 | -$49.57M | -37.1% |
| 2018 | -$36.16M | -31.4% |
| 2017 | -$27.51M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $315.78M | -31.1% | -13.3% |
| June 30, 2025 | $364.42M | -23.5% | -11.4% |
| March 31, 2025 | $411.08M | -18.5% | -6.3% |
| December 31, 2024 | $438.87M | -21.0% | -4.3% |
| September 30, 2024 | $458.52M | -21.2% | -3.8% |
| June 30, 2024 | $476.47M | -20.9% | -5.5% |
| March 31, 2024 | $504.37M | -18.4% | -9.2% |
| December 31, 2023 | $555.19M | -13.3% | -4.6% |
- Atea Pharmaceuticals, Inc. showed a decrease of -37.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Atea Pharmaceuticals, Inc.’s stockholders equity has grown by 1101.2% (from -$27.51 million to $275.43 million).
- The most recent figure is from Atea Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: